Literature DB >> 23534722

Gene polymorphism of XRCC1 Arg399Gln and cervical carcinoma susceptibility in Asians: a meta-analysis based on 1,759 cases and 2,497 controls.

Yi-Ting Liu1, Jing-Pu Shi, Ling-Yu Fu, Bo Zhou, Hai-Long Wang, Xiao-Mei Wu.   

Abstract

Many epidemiological studies in Asian populations have investigated associations between the Arg399Gln gene polymorphism of X-ray repair cross complementing gene 1 (XRCC1) and risk of cervical carcinoma, but no conclusions have been available because of controversial results. Therefore a meta-analysis was conducted for clarification. Relevant studies were identified by searching the Pubmed, Embase, the Web of Science, Cochrane Collaboration's database, Chinese National Knowledge Infrastructure (CNKI), Wanfang database and China Biological Medicinse (CBM) until September, 2012. A total of eight studies were included in the present meta- analysis, which described 1,759 cervical carcinoma cases and 2,497 controls. Odds ratios (ORs) and corresponding 95% confidence intervals (95%CIs) as effect size were calculated by fixed-effect or random-effect models. The overall results indicated that the XRCC1-399G/A polymorphism was marginally associated with cervical carcinoma in Asians: OR (95%CI): 1.16 (1.07, 1.26) in the G/A vs G/G inheritance model, 1.24 (0.87, 1.76)in A/A vs G/G inheritance model, 1.13 (1.01, 1.27) in the dominant inheritance model and 1.18 (0.94, 1.47) in the recessive inheritance model. Subgroup analyses on sample size showed no significant correlation in the small- sample size group but the large-sample size group was consistent with the outcomes of overall meta-analysis. In the subgroup analysis by regions, we only found significant association under the G/A vs G/G inheritance model in the Chinese population. For the non-Chinese populations, no correlation was detected in any genetic inheritance model. In the Asian populations, XRCC1-399G/A gene polymorphism was implied to be associated with cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23534722     DOI: 10.7314/apjcp.2013.14.1.189

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  XRCC1 polymorphisms and cervical cancer risk: an updated meta-analysis.

Authors:  Jie Mei; Hai-Xia Duan; Ling-Ling Wang; Sen Yang; Jie-Qiang Lu; Ting-Yan Shi; Yu Zhao
Journal:  Tumour Biol       Date:  2013-09-21

Review 2.  The association between cytotoxic T lymphocyte-associated antigen-4 and cervical cancer.

Authors:  Ping Liu; Li Xu; Yuan Sun; Zhiping Wang
Journal:  Tumour Biol       Date:  2013-12-10

3.  Identification of XRCC1 Arg399Gln and XRCC3 Thr241Met Polymorphisms in a Turkish Population and Their Association with the Risk of Chronic Lymphocytic Leukemia.

Authors:  Pelin Mutlu; Mualla Pınar Elçi; Murat Yıldırım; Oral Nevruz; Ahmet Türker Çetin; Ferit Avcu
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-11       Impact factor: 0.900

4.  Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis.

Authors:  Yadong Wang; Xinwei Chu; Xiaojing Meng; Fei Zou
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

5.  Association Between XRCC1 and WRN as Genetic Markers of Stability and Susceptibility to Cancer in Patients with HIV/AIDS and Cancer: a Cross-Sectional Study

Authors:  Gabriel de Carvalho Maldonado; Orlando Nascimento Terra Júnior; Adriano Arnóbio; Guilherme Rohem Alfradique; Maria Helena Ornellas; Roberto Irineu da Silva; Dirce Bonfim de Lima
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

6.  Meta-analysis of XRCC1 polymorphism and risk of female reproductive system cancer.

Authors:  Na-Na Yang; Ying-Fan Huang; Jian Sun; Ying Chen; Zhong-Min Tang; Jin-Fang Jiang
Journal:  Oncotarget       Date:  2017-04-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.